{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T13:11:34Z","timestamp":1790082694304,"version":"4.0.1"},"reference-count":35,"publisher":"Wiley","license":[{"start":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T00:00:00Z","timestamp":1790035200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"},{"start":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T00:00:00Z","timestamp":1790035200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Annals of Neurology"],"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>As leptomeningeal metastasis (LM) has a poor prognosis, reliable cerebrospinal fluid (CSF) diagnostic biomarkers are urgently needed. This study evaluated the diagnostic value of CSF growth differentiation factor\u200915 (GDF15) in LM from lung adenocarcinoma (LUAD) and breast cancer (BC).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A cohort of 726 CSF samples, including those from patients with LUAD LM, LUAD without LM (LUAD Non\u2010LM; comprising LUAD without brain metastasis and LUAD with parenchymal brain metastasis), neurological controls, and patients with primary intracranial solid tumors, as well as a BC cohort of 83 CSF samples from BC LM and BC Non\u2010LM patients, were enrolled in the study. The GDF15 and carcinoembryonic antigen\u2010related cell adhesion molecule\u20096 (CEACAM6) levels were measured by the chemiluminescence method.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>CSF GDF15 levels were elevated &gt;25\u2010fold in LUAD LM compared with Non\u2010LM and neurological controls. CSF GDF15 excellently discriminated LUAD LM from Non\u2010LM (AUC 0.959 and 0.912) and neurological controls (AUC 0.975 and 0.929) in 2 independent cohorts. CSF GDF15 levels effectively distinguished LUAD LM from parenchymal brain metastasis (AUC 0.954) and primary intracranial solid tumors (AUC 0.950). High CSF GDF15 levels were associated with shorter overall survival in LUAD LM patients. CSF CEACAM6 similarly differentiated LUAD LM from parenchymal brain metastasis (AUC 0.956) and primary intracranial solid tumors (AUC 0.970). In the BC cohort, GDF15 (AUC 0.899) and CEACAM6 (AUC 0.869) both performed well in distinguishing LM from Non\u2010LM. The combination of GDF15 and CEACAM6 outperformed either biomarker alone in diagnosis of LUAD LM and BC LM.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Interpretation<\/jats:title>\n                    <jats:p>CSF GDF15 is a high\u2010performance diagnostic biomarker for LUAD LM and BC LM. ANN NEUROL 2026 ANN NEUROL 2026<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1002\/ana.78353","type":"journal-article","created":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T12:27:16Z","timestamp":1790080036000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["<scp>Growth Differentiation Factor 15<\/scp>\n                    as a Cerebrospinal Fluid Biomarker for the Diagnosis and Prognosis of Leptomeningeal Metastasis"],"prefix":"10.1002","author":[{"given":"Haoyu","family":"Ruan","sequence":"first","affiliation":[{"name":"Department of Laboratory Medicine The First Affiliated Hospital with Nanjing Medical University  Nanjing China"},{"name":"Branch of National Key Clinical Research Center for Laboratory Medicine  Nanjing China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine The First Affiliated Hospital with Nanjing Medical University  Nanjing China"},{"name":"Branch of National Key Clinical Research Center for Laboratory Medicine  Nanjing China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fuhai","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine The First Affiliated Hospital with Nanjing Medical University  Nanjing China"},{"name":"Branch of National Key Clinical Research Center for Laboratory Medicine  Nanjing China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine The First Affiliated Hospital with Nanjing Medical University  Nanjing China"},{"name":"Branch of National Key Clinical Research Center for Laboratory Medicine  Nanjing China"},{"name":"Huai'an Hospital Affiliated to Yangzhou University  Huai'an Jiangsu China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Luo","sequence":"additional","affiliation":[{"name":"Department of Cardiology Nanjing First Hospital, Nanjing Medical University  Nanjing China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Mu","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine The First Affiliated Hospital with Nanjing Medical University  Nanjing China"},{"name":"Branch of National Key Clinical Research Center for Laboratory Medicine  Nanjing China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine The First Affiliated Hospital with Nanjing Medical University  Nanjing China"},{"name":"Branch of National Key Clinical Research Center for Laboratory Medicine  Nanjing China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuqing","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine The First Affiliated Hospital with Nanjing Medical University  Nanjing China"},{"name":"Branch of National Key Clinical Research Center for Laboratory Medicine  Nanjing China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingping","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine The First Affiliated Hospital with Nanjing Medical University  Nanjing China"},{"name":"Branch of National Key Clinical Research Center for Laboratory Medicine  Nanjing China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunyun","family":"Ning","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine Suining People's Hospital  Xuzhou Jiangsu China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuan","family":"Deng","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine Huashan Hospital, Fudan University  Shanghai China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Guan","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine Huashan Hospital, Fudan University  Shanghai China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2032-251X","authenticated-orcid":false,"given":"Jian","family":"Xu","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine The First Affiliated Hospital with Nanjing Medical University  Nanjing China"},{"name":"Branch of National Key Clinical Research Center for Laboratory Medicine  Nanjing China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2026,9,22]]},"reference":[{"key":"e_1_2_9_2_1","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1158\/1078-0432.CCR-22-1585","article-title":"Leptomeningeal metastasis from non\u2010small cell lung cancer and current landscape of treatments","volume":"29","author":"Ozcan G","year":"2023","journal-title":"Clin Cancer Res"},{"key":"e_1_2_9_3_1","doi-asserted-by":"crossref","first-page":"240","DOI":"10.37349\/etat.2022.00081","article-title":"Endocrine resistant breast cancer: brain metastasis","volume":"3","author":"Willman M","year":"2022","journal-title":"Explor Target Antitumor Ther"},{"key":"e_1_2_9_4_1","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1007\/s11060-023-04483-4","article-title":"Effects of intrathecal pemetrexed on the survival of patients with leptomeningeal metastasis from lung adenocarcinoma: a propensity score matching analysis","volume":"165","author":"Hong Y","year":"2023","journal-title":"J Neuro\u2010Oncol"},{"key":"e_1_2_9_5_1","doi-asserted-by":"crossref","first-page":"2747","DOI":"10.1200\/JCO.24.00708","article-title":"Phase II efficacy and safety of 80 mg Osimertinib in patients with leptomeningeal metastases associated with epidermal growth factor receptor mutation\u2010positive non\u2010small cell lung cancer (BLOSSOM)","volume":"42","author":"Park S","year":"2024","journal-title":"J Clin Oncol"},{"key":"e_1_2_9_6_1","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1038\/s41571-024-00970-3","article-title":"Leptomeningeal metastatic disease: new frontiers and future directions","volume":"22","author":"Ozair A","year":"2025","journal-title":"Nat Rev Clin Oncol"},{"key":"e_1_2_9_7_1","first-page":"e521","article-title":"Circulating epithelial tumor cell analysis in CSF in patients with leptomeningeal metastases","volume":"94","author":"Bussel MTJ","year":"2020","journal-title":"Neurology"},{"key":"e_1_2_9_8_1","article-title":"Cellular landscape and diagnostic value of TROP2 in cerebrospinal fluid of lung adenocarcinoma leptomeningeal metastases","volume":"10","author":"Wang Z","year":"2026","journal-title":"npj Precis Oncol"},{"key":"e_1_2_9_9_1","doi-asserted-by":"crossref","DOI":"10.1002\/ctm2.885","article-title":"Single\u2010cell RNA sequencing reveals the characteristics of cerebrospinal fluid tumour environment in breast cancer and lung cancer leptomeningeal metastases","volume":"12","author":"Ruan H","year":"2022","journal-title":"Clin Transl Med"},{"key":"e_1_2_9_10_1","doi-asserted-by":"crossref","DOI":"10.1002\/ctm2.246","article-title":"Circulating tumor cell characterization of lung cancer brain metastases in the cerebrospinal fluid through single\u2010cell transcriptome analysis","volume":"10","author":"Ruan H","year":"2020","journal-title":"Clin Transl Med"},{"key":"e_1_2_9_11_1","doi-asserted-by":"crossref","DOI":"10.1038\/s41419-025-07695-w","article-title":"NAG\u20101\/GDF15 as a tumor suppressor in colorectal cancer: inhibition of beta\u2010catenin and NF\u2010kappaB pathways via interaction with EpCAM","volume":"16","author":"Lee J","year":"2025","journal-title":"Cell Death Dis"},{"key":"e_1_2_9_12_1","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.cytogfr.2021.11.002","article-title":"Pathophysiological role of growth differentiation factor 15 (GDF15) in obesity, cancer, and cachexia","volume":"64","author":"Siddiqui JA","year":"2022","journal-title":"Cytokine Growth Factor Rev"},{"key":"e_1_2_9_13_1","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1016\/j.trecan.2025.06.007","article-title":"GDF15: from biomarker to target in cancer cachexia","volume":"11","author":"Hullwegen M","year":"2025","journal-title":"Trends Cancer"},{"key":"e_1_2_9_14_1","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/j.tem.2024.09.002","article-title":"GDF15 is still a mystery hormone","volume":"36","author":"Sigvardsen CM","year":"2025","journal-title":"Trends Endocrinol Metab"},{"key":"e_1_2_9_15_1","doi-asserted-by":"crossref","DOI":"10.1111\/cns.14600","article-title":"GDF15 is a dynamic biomarker of the integrated stress response in the central nervous system","volume":"30","author":"Asundi J","year":"2024","journal-title":"CNS Neurosci Ther"},{"key":"e_1_2_9_16_1","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0248980","article-title":"Growth differentiation factor 15 increases in both cerebrospinal fluid and serum during pregnancy","volume":"16","author":"Andersson\u2010Hall U","year":"2021","journal-title":"PLoS One"},{"key":"e_1_2_9_17_1","doi-asserted-by":"crossref","DOI":"10.1016\/j.psyneuen.2024.107212","article-title":"Growth differentiation factor 15 during pregnancy and postpartum as captured in blood, cerebrospinal fluid and placenta: a cohort study on associations with maternal mental health","volume":"171","author":"Hogh S","year":"2025","journal-title":"Psychoneuroendocrinology"},{"key":"e_1_2_9_18_1","doi-asserted-by":"crossref","first-page":"2624","DOI":"10.1002\/ijc.24639","article-title":"Elevated levels of MIC\u20101\/GDF15 in the cerebrospinal fluid of patients are associated with glioblastoma and worse outcome","volume":"125","author":"Shnaper S","year":"2009","journal-title":"Int J Cancer"},{"key":"e_1_2_9_19_1","doi-asserted-by":"crossref","DOI":"10.1016\/j.esmoop.2024.102384","article-title":"Efficacy and safety of intrathecal pemetrexed for TKI\u2010failed leptomeningeal metastases from EGFR+ NSCLC: an expanded, single\u2010arm, phase II clinical trial","volume":"9","author":"Fan C","year":"2024","journal-title":"ESMO Open"},{"key":"e_1_2_9_20_1","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1136\/bmj.291.6487.29","article-title":"Respiratory consultations in asthmatic compared with non\u2010asthmatic children in general practice","volume":"291","author":"Levy M","year":"1985","journal-title":"Br Med J (Clin Res Ed)"},{"key":"e_1_2_9_21_1","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1339914","article-title":"Diagnostic value of cerebrospinal fluid human epididymis protein 4 for leptomeningeal metastasis in lung adenocarcinoma","volume":"15","author":"Li X","year":"2024","journal-title":"Front Immunol"},{"key":"e_1_2_9_22_1","doi-asserted-by":"crossref","first-page":"1962","DOI":"10.1016\/j.jtho.2016.06.029","article-title":"Leptomeningeal metastases in patients with NSCLC with EGFR mutations","volume":"11","author":"Li YS","year":"2016","journal-title":"J Thorac Oncol"},{"key":"e_1_2_9_23_1","doi-asserted-by":"crossref","first-page":"5906","DOI":"10.3390\/curroncol30060442","article-title":"Leptomeningeal metastasis: a review of the pathophysiology, diagnostic methodology, and therapeutic landscape","volume":"30","author":"Nguyen A","year":"2023","journal-title":"Curr Oncol"},{"key":"e_1_2_9_24_1","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1016\/j.cell.2017.02.025","article-title":"Complement component 3 adapts the cerebrospinal fluid for leptomeningeal metastasis","volume":"168","author":"Boire A","year":"2017","journal-title":"Cell"},{"key":"e_1_2_9_25_1","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1126\/science.aaz2193","article-title":"Cancer cells deploy lipocalin\u20102 to collect limiting iron in leptomeningeal metastasis","volume":"369","author":"Chi Y","year":"2020","journal-title":"Science"},{"key":"e_1_2_9_26_1","first-page":"1940","article-title":"Dura immunity configures leptomeningeal metastasis immunosuppression for cerebrospinal fluid barrier invasion","volume":"5","author":"Zhao J","year":"2024","journal-title":"Nat Can"},{"key":"e_1_2_9_27_1","first-page":"754","article-title":"Leptomeningeal metastatic cancer cells induce a permissive choroid plexus vasculature through extracellular\u2010vesicle\u2010derived 5\u2010HIAA signaling","volume":"7","author":"Huang Y","year":"2026","journal-title":"Nat Can"},{"key":"e_1_2_9_28_1","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.omtn.2018.05.016","article-title":"EZH2\u2010mediated epigenetic suppression of GDF15 predicts a poor prognosis and regulates cell proliferation in non\u2010small\u2010cell lung cancer","volume":"12","author":"Lu X","year":"2018","journal-title":"Mol Ther Nucleic Acids"},{"key":"e_1_2_9_29_1","first-page":"2379","article-title":"The role of GDF15 in bone metastasis of lung adenocarcinoma cells","volume":"41","author":"Duan L","year":"2019","journal-title":"Oncol Rep"},{"key":"e_1_2_9_30_1","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/s00432-022-04500-5","article-title":"Plasma GDF15 levels associated with circulating immune cells predict the efficacy of PD\u20101\/PD\u2010L1 inhibitor treatment and prognosis in patients with advanced non\u2010small cell lung cancer","volume":"149","author":"Hong G","year":"2023","journal-title":"J Cancer Res Clin Oncol"},{"key":"e_1_2_9_31_1","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2024.177127","article-title":"Metformin inhibits migration and epithelial\u2010to\u2010mesenchymal transition in non\u2010small cell lung cancer cells through AMPK\u2010mediated GDF15 induction","volume":"985","author":"Zhou H","year":"2024","journal-title":"Eur J Pharmacol"},{"key":"e_1_2_9_32_1","doi-asserted-by":"crossref","first-page":"3169","DOI":"10.1111\/jcmm.16360","article-title":"Serum macrophage inhibitory cytokine\u20101 as a clinical marker for non\u2010small cell lung cancer","volume":"25","author":"Xu C","year":"2021","journal-title":"J Cell Mol Med"},{"key":"e_1_2_9_33_1","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2017.434","article-title":"CDP138 silencing inhibits TGF\u2010beta\/Smad signaling to impair radioresistance and metastasis via GDF15 in lung cancer","volume":"8","author":"Lu Y","year":"2017","journal-title":"Cell Death Dis"},{"key":"e_1_2_9_34_1","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1186\/s12885-024-12727-3","article-title":"The impact of the expression level of growth differentiation factor 15 in tumor tissue on the response to immunotherapy in non\u2010small cell lung cancer","volume":"24","author":"Akdogan O","year":"2024","journal-title":"BMC Cancer"},{"key":"e_1_2_9_35_1","doi-asserted-by":"crossref","DOI":"10.1186\/s13014-024-02546-y","article-title":"Growth differentiation factor 15 (GDF15) predicts relapse free and overall survival in unresected locally advanced non\u2010small cell lung cancer treated with chemoradiotherapy","volume":"19","author":"Di Pastena F","year":"2024","journal-title":"Radiat Oncol"},{"key":"e_1_2_9_36_1","doi-asserted-by":"crossref","DOI":"10.1080\/07853890.2025.2489748","article-title":"Diagnostic value of CEACAM6 and HE4 in pleural fluid for malignant pleural effusion","volume":"57","author":"Li J","year":"2025","journal-title":"Ann Med"}],"container-title":["Annals of Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/ana.78353","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/ana.78353","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/ana.78353","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T12:27:21Z","timestamp":1790080041000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/ana.78353"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,22]]},"references-count":35,"alternative-id":["10.1002\/ana.78353"],"URL":"https:\/\/doi.org\/10.1002\/ana.78353","archive":["Portico"],"relation":{},"ISSN":["0364-5134","1531-8249"],"issn-type":[{"value":"0364-5134","type":"print"},{"value":"1531-8249","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,22]]},"assertion":[{"value":"2025-11-17","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-08-15","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-09-22","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"ana.78353"}}